Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (median age 34 years) in Germany. These data emphasize that nonpharmaceutical interventions for coronavirus disease remain crucia...

Full description

Bibliographic Details
Main Authors: Tatjana Schwarz, Pinkus Tober-Lau, David Hillus, Elisa T. Helbig, Lena J. Lippert, Charlotte Thibeault, Willi Koch, Irmgard Landgraf, Janine Michel, Leon Bergfeld, Daniela Niemeyer, Barbara Mühlemann, Claudia Conrad, Chantip Dang-Heine, Stefanie Kasper, Friederike Münn, Kai Kappert, Andreas Nitsche, Rudolf Tauber, Sein Schmidt, Piotr Kopankiewicz, Harald Bias, Joachim Seybold, Christof von Kalle, Terry C. Jones, Norbert Suttorp, Christian Drosten, Leif Erik Sander, Victor M. Corman, Florian Kurth
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-08-01
Series:Emerging Infectious Diseases
Subjects:
vaccine
mRNA
immunity
T cell
B cell
antibody
Online Access:https://wwwnc.cdc.gov/eid/article/27/8/21-1145_article

Internet

https://wwwnc.cdc.gov/eid/article/27/8/21-1145_article

Similar Items